VONACOR CAPSULES ARE A NEWLY FORMULATED MEDICAL FOOD FOR DIETARY MANAGEMENT OF OSTEOARTHRITIS UNDER PHYSICIAN SUPERVISION. Vonacor has potent anti-inflammatory properties and is available through physicians’ offices and pharmacies.
Vonacor uses patented microtechnology for 9.7 fold enhanced absorption and longer duration of therapeutic action (1). Vonacor has proven efficacy, a favorable safety profile, and is thoroughly tested for uniformity and purity and manufactured using certified Good Manufacturing Practices (GMP). Two 500 mg capsules of Vonacor taken in the morning have been shown to have excellent pain relief with reduced dependence on medications (2). Inflammation plays a major role in the development, progression, and pain associated with osteoarthritis. Anti-inflammatory medications (NSAIDs) traditionally recommended for osteoarthritis management have been associated with increased risk of heart disease, elevated blood pressure, peptic ulcer disease, and, especially in diabetics, kidney disorders(3). Vonacor is a natural product that uses patented microtechnology with each batch tested for consistency to maximize purity, potency, and absorption of curcumin. Curcumin is a turmeric root extract shown to reduce inflammation by blocking IL-1 (4).
Curcumin is comparable to ibuprofen in a multi-center clinical trial for managing knee osteoarthritis with better patient satisfaction reported in the curcumin group with a lower adverse effects profile (5).
Vonacor has great therapeutic efficacy and safety profile. Vonacor capsules should be the first-line option in managing osteoarthritis. A daily regimen of two 500 mg Vonacor capsules taken in the morning will reduce pain and increase mobility of osteoarthritis patients while reducing morbidities and dependence on prescription drugs.
VONACOR is a new, micronized formulation of curcuminin a sustained release matrix that allows for enhanced absorption.The results of the Madhavi single-dose uptake study (1) demonstrated that the sustained release formula was 9.7 times more bioavailable than an unformulated powder of curcumin. All participants showed uptake from the sustained release formulation and was well tolerated without adverse effects in the high-dose study. 1. Madhavi et al. Integ Med 2014: 13(3): 24-30 2. Vad et al. 2015 data to be published 3. Juni et al, BMJ 2011: 342:c7086 4. Jurman et al. J Nutr 2005: 135(8): 1859-1864 5. Kuptniratsaikul et al. J Alt Comp Med 2009: 15(8): 891-897
Made in USA by Vad Biolabs Vonacor.com
Vonacor Spec Sheet
“Bioavailability of a Sustained Release Formulation of Curcumin,” Doddabele Madhavi, PhD and Daniel Kagan, PhD, Integrative Medicine • Vol. 13, No. 3 • June 2014